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Abstract
Bluetongue virus (BTV) and epizootic haemorrhagic disease virus (EHDV) are related orbiviruses, transmitted between their
ruminant hosts primarily by certain haematophagous midge vectors (Culicoides spp.). The larger of the BTV outer-capsid
proteins, ‘VP2’, can be cleaved by proteases (including trypsin or chymotrypsin), forming infectious subviral particles (ISVP)
which have enhanced infectivity for adult Culicoides, or KC cells (a cell-line derived from C. sonorensis). We demonstrate that
VP2 present on purified virus particles from 3 different BTV strains can also be cleaved by treatment with saliva from adult
Culicoides. The saliva proteins from C. sonorensis (a competent BTV vector), cleaved BTV-VP2 more efficiently than those
from C. nubeculosus (a less competent / non-vector species). Electrophoresis and mass spectrometry identified a trypsin-like
protease in C. sonorensis saliva, which was significantly reduced or absent from C. nubeculosus saliva. Incubating purified
BTV-1 with C. sonorensis saliva proteins also increased their infectivity for KC cells,10 fold, while infectivity for BHK cells was
reduced by 2–6 fold. Treatment of an ‘eastern’ strain of EHDV-2 with saliva proteins of either C. sonorensis or C. nubeculosus
cleaved VP2, but a ‘western’ strain of EHDV-2 remained unmodified. These results indicate that temperature, strain of virus
and protein composition of Culicoides saliva (particularly its protease content which is dependent upon vector species), can
all play a significant role in the efficiency of VP2 cleavage, influencing virus infectivity. Saliva of several other arthropod
species has previously been shown to increase transmission, infectivity and virulence of certain arboviruses, by modulating
and/or suppressing the mammalian immune response. The findings presented here, however, demonstrate a novel
mechanism by which proteases in Culicoides saliva can also directly modify the orbivirus particle structure, leading to
increased infectivity specifically for Culicoides cells and, in turn, efficiency of transmission to the insect vector.
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Introduction
Arboviruses are transmitted between their mammalian hosts by
arthropod vectors (ticks, insects), which also become productively
infected by the virus. It has been demonstrated that in certain
cases the saliva from these arthropods can play an important role
in pathogen transmission mechanisms [1]. For example, West Nile
virus [2], Sindbis virus [3], Cache valley virus [4] and vesicular
stomatitis virus [5,6] are all more infectious and/or more virulent
if administered with saliva from their arthropod vector.
These effects are thought to be achieved primarily through the
effect of insect or tick saliva components on the mammalian
immune response [7]. Depending on saliva concentration, it was
suggested that these effects could involve an immune-response
modulation, which down-regulates specific antiviral cytokines
[6,8,9]. Alternatively the saliva could cause immune-suppression
in the mammalian host, enhancing virus infectivity and affecting
the hosts’ chances of survival [10,11].
The Bluetongue virus (BTV) and Epizootic haemorrhagic disease virus
(EHDV) species are both members of the genus Orbivirus, family
Reoviridae. BTV is one of the most economically important arboviruses
of domesticated ruminants (for review see [12]). Infected sheep and
some species of deer frequently develop a severe haemorrhagic
disease called bluetongue (BT), while a large proportion of infected
cattle and other wild ruminants may only develop subclinical
infections [13,14]. Since 2006 Europe has experienced the worst
‘single’ BT outbreak ever recorded (caused by a ‘western’ strain of
BTV-8 [15]), affecting many European countries, including those in
the north of the region with no previous history of the disease (e.g. the
Netherlands, Belgium, Germany, France and the UK) with case
fatality rates up to 50% [16].
EHDV can also cause severe disease in both deer and cattle and
has recently been included in the OIE notifiable disease list
(http://www.oie.int/eng/maladies/en_classification2009).
The orbivirus genome is composed of ten segments of linear
dsRNA, which code for a total of 10 distinct viral proteins:
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including three different non-structural proteins, and seven
structural proteins. Proteins VP1, VP3, VP4, VP6 and VP7 form
the icosahedral virus-core particle, which is surrounded by an
outer capsid layer composed of VP2 and VP5 [17]. These outer-
capsid components are the most variable of the viral proteins, and
are primarily involved in cell attachment and penetration of the
host cell during the early stages of infection [18,19,20]. They also
represent a target for neutralising antibodies (particularly VP2)
that are generated during infection of the mammalian host and
therefore determine the serotype of the individual strain [21]. All
of the virus genome segments, including those coding for the outer
capsid proteins, also show sequence variations that correlate with
the geographic origins of the virus isolate (topotype) [15,22]. The
most significant of these can be used to divide both BTV and
EHDV isolates into two major ‘Eastern’ and ‘Western’ groups.
Proteases (such as chymotrypsin) can cleave VP2, generating
infectious subviral particles (ISVP) which have an enhanced
infectivity for adult Culicoides and KC cells (a cell-line derived from
C. sonorensis) [23].
BTV and EHDV are transmitted between their ruminant hosts
almost exclusively by adult female Culicoides (one of the smallest of
the haematophagous insects) [24]. Although Culicoides saliva is
thought likely to play an important role in orbivirus transmission
mechanisms, its effects on the transmission efficiency, infectivity or
virulence of these viruses has not previously been reported. Our
knowledge of Culicoides saliva proteins and their functions had been
limited due to difficulties in collecting saliva from such small
insects. With the development of more advanced molecular
biology methods, cDNA expression libraries have been generated
for the salivary gland and midgut of C. sonorensis [25], as well as the
salivary gland of C. nubeculosus [26]. These techniques have the
potential to provide greater access to individual (expressed) protein
components of the insect’s saliva. However, they will not provide
information on their relative abundance in saliva, or the effects of
Culicoides saliva (as a whole) on virus structure and transmission.
We previously described an efficient method for the collection of
relatively large quantities of Culicoides saliva in a pure form, using
protein binding filters [27]. Indeed, sufficient saliva proteins were
collected from C. nubeculosus (an inefficient BTV vector from
Europe) for direct protein sequencing by mass spectrometry [27].
Here we report the effect of saliva proteins from a competent
BTV / EHDV vector (C. sonorensis) and an inefficient vector (C.
nubeculosus) on the structure (and outer capsid components) of
purified BTV and EHDV particles, as well as their effect on the
infectivity of BTV for KC cells (derived from C. sonorensis). The
results obtained show that proteases in the saliva of adult Culicoides
can directly modify the structure and the infectivity of the
orbiviruses they transmit, through cleavage of the outermost viral
protein. The efficiency of cleavage is shown to be dependent on
temperature, protein composition of the saliva (which varies
between different Culicoides spp.) and the protease susceptibility of
VP2 from individual virus strains.
Results
Identification of a ,29 kD trypsin protein in C. sonorensis
saliva
One dimensional electrophoresis identified a prominent ,29–
30 kDa protein in C. sonorensis saliva, however, comparing similar
quantities of both species saliva the 29 kDa protein seemed to be
absent from C. nubeculosus saliva (Figure 1). Similar protein profiles
were obtained from at least 4 independent saliva collections and
preparations from both species. One dimensional SDS-PAGE of
large amounts ($50 mg) of C. nubeculosus saliva proteins showed
two faint bands in the area between 27–32 kDa, however the
quantities of any proteins which migrated between 27 kDa–
33 kDa were insufficient to allow identification by tandem mass
spectrometry (not shown). Contrary the ,29 kDa protein was one
of the major identifiable proteins in at least 6 independently
collected C. sonorensis saliva preparations. It was therefore
concluded that the 29 kDa protein is present in C. sonorensis saliva
at least in vastly greater amounts.
Two-D separation and mass spectrometry analysis of this
protein from C. sonorensis saliva, generated the 17 amino-acid long
sequence ‘TSAWSSSSDQLNFVDMR’. This is identical to a
region of ‘late-trypsin’ previously reported from a C. sonorensis
cDNA library (UniProt Q66UC8_9DIPT, total length 275 AA -
[25]). The presence of late-trypsin in C. sonorensis saliva was
confirmed by the presence of additional peptides in further mass
spectrometry analyses (unpublished data). The predicted molecu-
lar mass of the whole protein is 29.5 kDa, which coincides with its
position during 1-D SDS-PAGE (Figure 1). No visible differences
were observed after these analyses, between the saliva proteins
from adult C. sonorensis derived from insect colonies that had been
bred to be susceptible, or refractory to BTV infection [28,29] (data
not shown).
A sequence comparison of late trypsin from C. sonorensis, using
the NCBI protein comparison and UniProt database, showed that
it is most closely related to other insect trypsin or serine proteases,
including a trypsin from C. nubeculosus (67% identity), tryptase-2
from Culex quinquefasciatus (46% identity) and serine protease from
Aedes aegypti (47% identity).
Figure 1. SDS-PAGE analysis of purified saliva from C.
nubeculosus and C. sonorensis. Purified saliva proteins (20 mg) from
C. nubeculosus (lane 1) and C. sonorensis (lane 2) were analysed on 15%
SDS-PAGE and visualized using silver staining. A representative figure of
at least four separate and independent saliva collections is shown. A
cluster of saliva proteins was identified between 40–70 kDa and 13–
17 kDa molecular weight for both species. However C. sonorensis saliva
has an additional prominent protein band at around 29 kDa (arrow),
which was identified as ‘‘late trypsin’’ using mass spectrometry analysis.
The presence of this 29 kDa protein in C. sonorensis saliva was
consistent in 5 independent saliva collections.
doi:10.1371/journal.pone.0017545.g001
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Cleavage of the outer coat protein VP2 of different BTV
strains by saliva from C. sonorensis (susceptible and
refractory strains) and C. nubeculosus
Proteases such as chymotrypsin have previously shown to be
able to cleave the outer-coat protein of purified BTV particles
[30]. In order to determine if proteases identified in the saliva of C.
sonorensis have a similar effect on the outer-coat protein VP2 of
different BTV strains, purified virus particles were incubated at
different temperatures in the presence and absence of saliva
proteins. SDS-PAGE analyses of secreted saliva of C. nubeculosus
[27], as well as those using whole salivary glands extracts [31]
failed to identify detectable amounts of proteases similar to the late
trypsin identified in C. sonorensis saliva. Additionally IAH Pirbright
holds two colonies of C. sonorensis, which contain insect strains that
were previously selected for their ability, or inability, to transmit
BTV [29,32], referred to as ‘susceptible’ and ‘refractory’
respectively. The ability of saliva proteins from both of the C.
sonorensis strains and C. nubeculosus to cleave the outer coat protein
of BTV was compared to identify any differences in the effects on
BTV caused by saliva from vector or non-vector Culicoides species.
Incubation of BTV-16 (RSAvvvv/16 or RSArrrr/16) virus
particles with C. sonorensis saliva proteins resulted in complete
cleavage of VP2 while only partial digestion of VP2 occurred after
treatment with saliva proteins from C. nubeculosus under the same
conditions (Figure 2, lanes 2 and 3). A large cleavage product
(,110 kDa) was generated (Figure 2).
Purified BTV-1 (RSArrrr/01) virus particles, incubated in the
absence of proteases, contained the major structural proteins of
BTV (Figure 3, lane 1). Treatment with 0.5 mg or 1 mg of C.
sonorensis saliva proteins (lanes 1 and 2) resulted in complete
cleavage of VP2, generating two major breakdown products
migrating at ,110 kDa and ,67 kDa respectively. VP2 was also
completely cleaved by treatment with either 1 or 0.5 mg of
trypsin, generating the same breakdown products (Figure 3, lanes
8 and 9 ).
BTV-1 VP2 was completely cleaved by saliva proteins from
both susceptible and refractory colonies of C. sonorensis, with similar
efficiencies and cleavage products (Figure 3 lanes 2 and 3 vs. lanes
4 and7). Although similar sized breakdown products were
generated, again only partial digestion of VP2 occurred after
treatment with saliva proteins from C. nubeculosus under the same
conditions (Figure 3 lanes 5 and 6).
The efficiency of VP2 cleavage appeared to be a function of the
amount of C. sonorensis saliva proteins in the reaction, incubation
time and temperature. Although cleavage of BTV VP2 by C.
sonorensis saliva proteins occurred over a wide range of tempera-
tures, from 4uC–37uC, only partial cleavage of VP2 was detected
under suboptimal conditions (Figure 4 and 5). Cleavage of VP2
BTV-1 (RSArrrr/01) was also shown to be a step-wise process,
with intermediate cleavage products detected at lower tempera-
tures (Figure 4) or lower amounts of proteases (Figure 5). At near
optimal cleavage conditions these intermediate breakdown
products are digested further until only the final breakdown
products remain present (Figure 4 and 5).
The susceptibility of EHDV-2 VP2 to cleavage by
Culicoides spp. saliva differs between virus strains
In order to establish if the cleavage of the outer coat protein by
Culicoides spp. saliva is a universal feature of orbiviruses, the effect of
C. sonorensis saliva on two strains of EHDV-2 was investigated.
VP2 of an eastern EHDV-2 strain (AUS1979/05) [33] was
completely cleaved by saliva proteins from either C. sonorensis or C.
nubeculosus (Figure 6). In contrast, incubation of a western EHDV-2
strain (CAN1962/01) [33] with the saliva proteins from either
Culicoides spp., for 3 h at 37uC degrees, had little effect, and intact
VP2 protein was still detected after incubation (Figure 6, lanes 2
and 3).
Although a band comparable to one of the major BTV-VP2
breakdown products (migrating slightly faster than VP3 at
,110 kDa) was present in samples of AUS1979/05 after
treatment with saliva, a band of a similar size was also present
in the ‘mock-treated’ control lanes that also contained intact VP2
of both EHDV strains (Figure 6).
Effect of protease inhibitors on the protease activity of C.
sonorensis saliva ability to cleave BTV-1 VP2
In order to further investigate if the protease activity in C.
sonorensis is solely due to the identified ‘‘late trypsin’’ and to
compare the reactivity of the insect derived proteases and
Figure 2. Saliva proteins from C. sonorensis cleave VP2 of BTV-
16 more efficiently than saliva proteins from C. nubeculosus.
Purified BTV-16 (RSAvvvv/16) virus particles (2 mg) were incubated for
3 hours at 37uC as a mock (lane 1) or with purified saliva proteins (2 mg)
from either C. sonorensis or C. nubeculosus and BTV viral proteins were
analyzed on a 12% SDS-PAGE using silver-staining for visualization. M
represents the molecular weight markers. Lane 1: purified BTV-16 virus
particles (2 mg); lane 2: purified BTV-16 virus particles incubated with C.
sonorensis saliva proteins; lane 3: BTV-16 incubated with C. nubeculosus
saliva proteins; lane 4: 2 mg of C. nubeculosus saliva proteins; lane 5:
2 mg of C. sonorensis saliva proteins. Outer capsid protein VP2 of BTV-16
(black arrow) was mostly cleaved by the C. sonorensis saliva proteins
(lane 2), while only partial cleavage occurred with C. nubeculosus saliva
proteins (lane 3). The cleavage of VP2 resulted in a cleavage product
(CP) migrating at 110 kDa just underneath VP3. No further breakdown
products of VP2 could be identified in these cleavage experiments. The
red arrow indicates the 29 kDa trypsin like protein in C. sonorensis saliva
and demonstrates its relative abundance compared to C. nubeculosus
saliva. Figure 2 is a representative picture from 3 independent
experiments.
doi:10.1371/journal.pone.0017545.g002
Culicoides Saliva Modifies Bluetongue Virus
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17545
mammalian trypsin and chymotrypsin to inhibition, the cleavage
of BTV-1 VP2 by these proteases was investigated in the presence
or absence of different inhibitors.
Cleavage of BTV-VP2 at any of the trypsin concentrations
(0.05–0.5 mg/50 ml), or the lower concentrations of chymotrypsin
(0.001 mg–0.01 mg/50 ml), was completely prevented by 1 mg
Bowman-Birk serine protease inhibitor (BBI) ‘Glycine max’.
Although VP2 cleavage by 1 mg C. sonorensis saliva proteins, or
the higher concentrations of chymotrypsin (0.05 mg/ 50 ml) was
only partially inhibited under these conditions, in both cases it was
completely prevented by addition of 20 mg of BBI (Examples
shown in Figure 7A).
The addition of 30 mg of a-antichymotrypsin to the reaction
(50 ml) completely prevented cleavage of VP2 at any of the
chymotrypsin concentrations used (0.001 mg–0.5 mg/ 50 ml) but
had no affect on the cleavage of BTV-1 VP2 by trypsin (Examples
shown in Figure 7B). Cleavage of BTV-1 VP2 by 1 mg C. sonorensis
saliva proteins was partially inhibited by the addition of 30 mg of
a-anti-chymotrypsin (Figure 7B).
Addition of 2 mg of trypsin-inhibitor S-II (TInh) to the reaction
(50 ml) prevented cleavage of BTV-1 VP2 by 0.5 mg trypsin
(Figure 7C), while cleavage by 0.5 mg chymotrypsin was unaffected
(not shown). However, TInh (trypsin-inhibitor S-II) did have some
effect on chymotrypsin, reducing cleavage by lower concentrations
of the enzyme (0.05–0.001 mg/ 50 ml) (Figure 7C). Cleavage of
BTV-1 VP2 by 1 mg C. sonorensis saliva proteins was also only
partially prevented using 2 mg or 4 mg of the trypsin-inhibitor S-II
(TInh) (Figure 7C).
The effect of C. sonorensis saliva on BTV-1 infectivity for
BHK and KC cells
It has previously been reported that infectious subviral particles
(ISVP) of BTV generated by cleavage of VP2 using chymotrypsin,
have a higher specific infectivity (10–100 times) for insect cells (KC
cells) and adult Culicoides, as compared to the intact virus particle
[23]. The possibility that that cleavage of VP2 by C. sonorensis saliva
may have the same effect on the infectivity of the virus for insect
cells was therefore investigated.
Treatment of purified virus particles of BTV-1 (2.5 mg) with
higher concentrations of C. sonorensis saliva proteins (10 or 15 mg
per 100 ml reaction), increased their specific infectivity for KC cells
by,10 fold (from an average of 107.7 TCID50/ml to an average of
108.7 TCID50/ml - Figure 8A) but reduced their infectivity for
BHK cells by ,3–6 fold (from an average of 107.6 TCID50/ml to
an average of 106.8 to 107.1 TCID50/ml). Addition of 5 mg of the
C. sonorensis saliva proteins produced a similar but less pronounced
effect, with the virus titre on KC cells being increased to an
average of 108.5 TCID50/ml, however, the titre for BHK cells
remained almost unchanged (at 107.6 TCID50/ml).
Treatment with either 1 or 5 mg of trypsin also increased the
infectivity of BTV-1 for KC cells by ,12 fold (to an average of
108.8 TCID50/ml - Figure 8B). A 2 fold increase in infectivity for
BHK cells was observed after treatment with 1 mg of trypsin, while
a 2 fold decrease was detected using 5 mg of trypsin (Figure 8B).
Three different amounts of chymotrypsin (0.5 mg, 1 mg and 5 mg
per reaction) were used to treat purified particles of BTV-1. In
each case an increase in specific infectivity of least 10 fold was
observed for KC cells (from an average of 107.7 TCID50/ml to
,108.8 TCID50/ml). In contrast the infectivity of treated particles
for BHK cells decreased by 10 to 25 fold (from an average of 107.6
TCID50/ml to 10
6.2 TCID50/ml for 5 mg of chymotrypsin
respectively) (Figure 8C).
Discussion
The saliva of adult Culicoides contains proteases that can cleave
VP2 of BTV and at least some strains of EHDV. This cleavage
changes the structure of the virus particle outer capsid, generating
infectious subviral particles (ISVP), and thereby increases the
infectivity of treated BTV particles ,tenfold for KC cells (derived
from C. sonorensis) (Figure 8). This represents the first demonstra-
tion that the structure and infectivity of a pathogen can be directly
modified by saliva proteases from its insect vector.
Purification methods previously developed for different BTV
particle types [30] had shown that VP2 in the BTV outer capsid
can be cleaved by chymotrypsin, and that generated ISVP have an
enhanced infectivity for KC cells and adult Culicoides [23].
The saliva of C. sonorensis, a major North American vector for
BTV, cleave VP2 more efficiently than those from C. nubeculosus,
which is a ‘poor’ or ‘non-vector’ species [34]. Electrophoresis and
mass spectrometry showed that ‘late trypsin’ (,29 kDa), identified
through sequence homology with a ‘late trypsin’ previously
reported in a cDNA expression library of C. sonorensis salivary
Figure 3. C. sonorensis saliva or trypsin control cleave VP2 of
BTV-1 particles, more efficiently than C. nubeculosus saliva.
Purified BTV-1 (RSArrrr/01) viral particles (2.5 mg) were incubated for
3 hours at 37uC either on its own as mock (lane 1) or with 0.5 or 1 mg
saliva proteins from C. sonorensis susceptible (lanes 2 & 3), C. nubeculosus
(lanes 5& 6) or C. sonorensis refractory (lanes 4&7) or with 1 or 0.5 mg
trypsin as positive controls (lanes 8 & 9). M represents the molecular
weight markers. Viral proteins were analysed by 10% SDS-PAGE and
visualized by silver staining. BTV-1 VP2 protein (short arrow-lane 2) was
completely cleaved by the saliva from both C. sonorensis strains (lanes
2&3 and 4&7) and by the control protease trypsin (lanes 8&9), resulting
in two dominant cleavage products (CP) running at 110 kDa and
67 kDa respectively. Incubation with C. nubeculosus saliva proteins only
resulted in partial cleavage of VP2 (lanes 5&6). VP2 cleavage products
are either not detectable yet using 0.5 mg of C. nubeculosus saliva
proteins (lane 5) or the smaller CP just starts to appear using 1 mg of C.
nubeculosus saliva proteins. Due to a lower amount of saliva used many
saliva proteins are not clearly identifiable on this SDS-PAGE. The 29 kDa
sized protein identified as late trypsin (red arrow) is just visible in the
lanes containing C. sonorensis saliva (lane 2,3,4 and 7).
doi:10.1371/journal.pone.0017545.g003
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Figure 4. Efficiency of BTV-1 VP2 cleavage by C. sonorensis saliva is temperature dependent. BTV-1 particles (2 mg) were incubated with
1 mg of C. sonorensis saliva proteins at 4uC, 10uC, 15uC, 20uC, 25uC or 37uC for 2 hours in a final volume of 50 ml. Viral proteins were analysed on 10%
SDS-PAGE and visualized using silver staining. Lane M shows molecular weight markers. Lane 1 and 8 are purified BTV-1 virus particles incubated at
37uC in the absence of proteases. After incubation at 4uC and 10uC (lane 2 and 3) intact BTV-1 VP2 was still visible, however some cleavage of VP2 had
occurred resulting in intermediate cleavage products (ICP). At 15uC, no intact VP2 was visible but still only intermediate cleavage products (ICP) are
generated. (lane 4). At higher temperatures, intermediate CP were completely cleaved to final CP (lane 7).
doi:10.1371/journal.pone.0017545.g004
Figure 5. Comparison of the effect of different amounts of C. sonorensis saliva, trypsin and chymotrypsin. Purified BTV-1 virus particles
(2.5 mg) were incubate at 37uC for 30 minutes in a final volume of 50 ml using different amounts of C. sonorensis saliva proteins (S) , trypsin (T) and
chymotrypsin (CT). BTV proteins were analyzed on a 10% SDS-PAGE using silver-staining for visualization. Lane 1: no proteases; lane 2: +2 mg S; lane 3:
+1 mg S; lane 4: +0.5 mg S; lane 5: +1 mg T; lane 6: +0.5 mg T; lane 7: +0.1 mg T; lane 8: +0.05 mg T; lane 9: +0.05 mg CT; lane 10: +0.01 mg CT: lane 11:
+0.005 mg CT; lane 12: +0.001 mg CT. The same levels of BTV-1 VP2 cleavage were obtained with 2.0 mg of C. sonorensis saliva proteins, 0.5 mg of
trypsin or an estimated 0.008 mg of chymotrypsin. For all three different proteases, C. sonorensis saliva, trypsin or chymotrypsin it can be seen that
using lower amounts of proteases generates intermediate cleavage products (ICP) (e.g. lane 3 and 4, lane 7 and 8 and lane 12) which are further
cleaved using higher amounts of proteases, leading to the two final VP2 cleavage products (CP) migrating at ,110 kDa and ,67 kDa respectively
(e.g. lane 2, lane 5 and lane 9 and 10).
doi:10.1371/journal.pone.0017545.g005
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glands (AY603563/ Q66UC8_9DIPT - [25]), is a relatively
abundant component of C. sonorensis secreted saliva (Figure 1).
Although C. nubeculosus saliva also showed some protease
activity, it contained only a very ‘faint’ protein band at
,29 kDa during SDS-PAGE, which provided insufficient material
for protein sequencing.
A cDNA expression library established from salivary glands of
C. nubeculosus by Russell et. al. (2009) [26], reported two trypsin like
proteases. These proteins, which had predicted sizes of 27.8 kDa
and 35.03 kDa (accession number ACM4087 and ACM40901
respectively), are distinctly different in size and sequence from the
late trypsin identified from C. sonorensis (AY603563- [25]). The
saliva protein sequences that were generated from cDNA libraries
for C. sonorensis [25] or C. nubeculosus [26] also show only relatively
low levels of sequence homology, suggesting that homologous
proteins are not highly conserved between these two species
[26,31]. Additional SDS-PAGE analyses of secreted saliva proteins
of C. nubeculosus [27], as well as those using whole salivary glands
extracts [31] also failed to detect any obvious proteins between
25 kDa and 37 kDa, despite the use of both 1 and 2-D gel analysis
and/ or direct sequencing by mass spectrometry. These data
indicate that trypsin like proteases are present in much lower
quantities in C. nubeculosus saliva. These differences in the protein
sequence, composition and relative quantities of individual
protease(s) in insect vector saliva, potentially could modulate the
vector competence levels of different Culicoides species.
Certain ‘barriers’ have been shown to exist within individual
adult Culicoides, which can prevent or constrain the initial infection,
replication and internal dissemination of ingested orbiviruses.
They include: a mesenteron infection barrier (MIB); a mesenteron
escape barrier (MEB); and a dissemination barrier (DB) [24,
28,35].
Differences between the saliva proteins (particularly the
proteases) between vector and non-vector Culicoides spp. and their
relative ability to digest VP2, enhancing the infectivity of ingested
orbivirus particles, could affect the initial stages of virus/cell
interactions and infection of the insect midgut. These differences
could therefore represent an important component of the MIB.
Previously it was demonstrated that proteolytic enzymes, including
those present in the mosquito midgut, can remove the outer coat
glycoprotein G1:a of La Crosse virus (Bunyaviridae), thereby
increasing virus affinity for mosquito cells [36]. The Culicoides
sonorensis midgut also contains proteases, as demonstrated in a
cDNA-library expression study [25] and the infectivity of a BTV-1
strain for adult C. sonorensis was reduced if the virus–bloodmeal
contained protease inhibitors [23]. However the efficiency of BTV
VP2 cleavage by Culicoides midgut proteases, and whether these
midgut proteases vary in cleavage efficiency between Culicoides
species, is currently unknown.
The work presented here not only shows that saliva proteases in
the saliva of the competent vector C. sonorensis can effectively cleave
BTVVP2 to form ISVP, it also demonstrates the cleavage efficiency
of BTV VP2 is influenced by the enzyme-virus particle ratio.
Ingestion of the insect’s saliva will increase the overall level of
proteases present in the gut environment, thereby also increasing
the relative efficiency of particle conversion to ISVP (and
consequently infectivity for the insect). Uptake of Culicoides saliva
by the feeding insect is very likely due to the nature of the ingestion
mechanism. Unlike mosquitoes Culicoides are ‘pool’ feeders [37];
using a rasping proboscis to create a small wound in the skin,
followed by the uptake of the material influx into this ‘‘pool’’ –
which includes blood, lymph, lymph cells and the inoculated saliva.
Therefore it is likely that during this process at least part of the BTV
outer-coat cleavage by saliva enzymes takes place within the
mammalian host’s skin, which is held at 30–37uC. This not only
gives a period for interaction between virus and saliva proteases
prior to ingestion, it also makes this stage of the digestion
mechanism more independent of environmental temperatures.
The saliva proteins collected and purified from vector competent
and refractory colonies of C. sonorensis, were very similar by SDS-
PAGE, and there was no detectable differences in their efficiency of
VP2 cleavage. However as only a proportion of individuals within
the competent vector colony of C. sonorensis will become infected,
further work is needed to investigate saliva protein compositions
between competent and refractory individuals.
Cleavage of VP2 from BTV-1 or BTV-16 (western and eastern
BTV topotypes respectively – [38]) by Culicoides saliva proteins,
suggests that this may be a generalised mechanism involved in the
Figure 6. The ability of Culicoides saliva to cleave EHDV VP2
depends on the strain of EHDV. Purified EHDV-2 virus particles
(1 mg) from two different strains, either CAN1962/01 or AUS1979/05,
were incubated in a final volume of 50 ml for 3 hours at 37uC with or
without saliva proteins (1 mg) from either C. sonorensis or C.
nubeculosus. Viral proteins were analysed on 12% SDS-PAGE and
visualised using silver staining. Lane M indicates molecular weight
markers. Lane 1: CAN1962/01 virus particles; lane 2: CAN1962/01 virus
particles with C. sonorensis saliva proteins; lane 3: CAN1962/01 virus
particles with C. nubeculosus saliva proteins; lane 4: AUS1979/05 virus
particles; lane 5: AUS1979/05 virus particles with C. sonorensis saliva
proteins; lane 6: AUS1979/05 virus particles with C. nubeculosus saliva
proteins. EHDV VP2 of the AUS1979/05 strain (black arrow) was cleaved
by the saliva proteins from either Culicoides species and intact VP2 was
not detected (lanes 5 & 6). In contrast EHDV VP2 of strain CAN1962/01
(white arrow) was still intact in the presence of saliva proteins from
either Culicoides species (lanes 2 and 3). The black and white arrows
indicate the VP2 proteins, which migrate at different size for the two
different EHDV-2 strains. The red arrows highlight the 29 kD protein
identified as late trypsin in the C. sonorensis saliva.
doi:10.1371/journal.pone.0017545.g006
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Figure 7. The effect of different protease inhibitors on C. sonorensis saliva, trypsin or chymotrypsin. BTV-1 purified virus particles were
incubated with different amounts of C. sonorensis saliva proteins (S), trypsin (T) or chymotrypsin (CT) in a final volume of 50 ml for 30 minutes at 37uC,
in the presence or absence of the following protease inhibitors : Bowman-Birk serine protease inhibitor (BBI); a-chymotrypsin inhibitor (CTInh) and
Trypsin Inhibitor SII (Tinh). The viral proteins were analysed on 10% SDS-PAGE and visualized using silver staining. Lane M indicates molecular weight
markers. Each reaction contained 2.5 mg BTV-1 particles with the different additions listed for each lane. Panel A: lane 1: mock treated virus particles,
lane 2: +1 mg S, lane 3: +1 mg S and 1 mg BBI, lane 4: +1 mg S and 20 mg BBI, lane 5: +0.05 mg CT, lane 6: +0.05 mg CT and 1 mg BBI, lane 7: +0.05 mg CT
and 20 mg BBI, lane 8: +0.5 mg T, lane 9: +0.5 mg T and 1 mg BBI. (Picture generated from one gel, not all lanes shown). Cleavage of BTV-1 VP2 by all
three different proteases is prevented in the presence of the serine protease inhibitor, however C. sonorensis saliva proteins and chymotrypsin need a
higher concentration of inhibitor to completely inhibit protease activity. Panel B: lane 1: mock treated virus particles, lane 2: +0.5 mg T, lane 3: +1 mg S,
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uptake and / or transmission pathway of different BTV serotypes
and topotypes. Although VP2 of an ‘eastern’ EHDV-2 ‘AUS1979/
05’ was also cleaved by treatment, VP2 of the western EHDV
strain ‘CAN1962/01’ remained intact, despite prolonged incuba-
tion. This indicates that not all orbiviruses have VP2 cleavage sites
that are appropriate for the saliva proteases of these particular
Culicoides species. VP2 from both of these EHDV-2 strains has a
predicted size of 982 AA, with 26.2% amino acid sequence
variation between them, although the major VP2 band of
AUS1979/05 migrates slightly more slowly during SDS-PAGE
[33,39] (Figure 6). Numerous potential trypsin and / or
chymotrypsin cleavages sites were identified during sequence
analysis of Seg-2 / VP2 from CAN1962/01 or AUS1979/05,
some of which are unique to either protein. If one or more of these
unique sites is essential for VP2 cleavage it may explain the
stability of the protein from CAN1962/01.
The protease activity of C. sonorensis saliva appears likely to be
mediated by one or more serine proteases, as indicated by its
sensitivity to the Bowman-Birk inhibitor, and is likely to be at least
partly due to the late trypsin identified here. However, the
protease activity of C. sonorensis saliva seemed to be less sensitive to
inhibition by BBI or trypsin inhibitor (S-II) than mammalian
trypsin or chymotrypsin (Figure 7A and 7C). C. sonorensis saliva
proteases were also partially sensitive to inhibition by a-antic-
hymotrypsin. This suggests that a second (chymotrypsin like) serine
protease may also be present in the saliva, which is inhibited by a-
antichymotrypsin, allowing partial cleavage of BTV-1 VP2 by the
unaffected trypsin activity (Figure 7B). However no other serine
protease (apart from the late-trypsin) was identified during 2-D gel
electrophoresis or mass spectrometry of C. sonorensis saliva, or by
salivary glands transcriptome analysis [25]. Alternatively, given the
structural differences between trypsin like proteases derived from
insects and mammals it could be possible that the Culicoides derived
trypsin- like proteases react less sensitive or less specific with these
inhibitors than their mammalian counterpart.
Protease treatment of purified BTV-1 virus particles can
significantly increase their specific-infectivity for KC cells
(Figure 8). This increase in BTV-1 infectivity was more
pronounced at the higher proteases concentrations used
(Figure 8) and initial results (not shown) showed minor changes
in infectivity using relatively low amounts of proteases (e.g. 0.1 mg
chymotrypsin, 0.5 mg trypsin or 1 mg C. sonorensis saliva proteins),
despite the fact that BTV-1 VP2 was almost completely cleaved by
those smaller amounts of protease when tested by SDS-PAGE
(Figure 5). The cleavage of BTV-1 VP2 at different temperatures
or different concentrations of C. sonorensis saliva proteins suggest
that intermediate breakdown products are initially formed, which
are then processed further (Figures 4 and 5). It therefore appears
likely that the initial cleavage of VP2 does not in itself alter BTV
infectivity, and further processing or cleavage of VP2 is needed to
increase specific infectivity.
The importance of saliva-modified virus-particles during
transmission of BTV from the insect to the ruminant host is
currently unknown. Previous analyses of C. nubeculosus or C.
sonorensis have identified protease inhibitors in the saliva [25,27].
These may at least partially inhibit the proteolytic enzymes within
the salivary gland, only allowing them to become fully active once
the inhibitors are diluted and the temperature is increased during
feeding on the mammalian host. However, it appears likely that
these proteolytic enzymes will modify the virus particles that are
generated by replication within the salivary glands, during or
immediately after their inoculation. As a consequence ISVP or
core particles could play a significant role in the early stage of
infection of the mammalian host.
In the work presented here, treatment of purified BTV particles
with Culicoides saliva proteins, modified their outer-capsid proteins
and reduced overall infectivity for BHK cells. In contrast, previous
studies showed that when crude cell culture material was treated
with proteases prior to purification these purified BTV ISVP
retained a similar specific-infectivity to that of the fully intact virus
particle for BHK cells and, similar to results presented here, an
increased infectivity for KC cells [23,30]. Additionally purified
core particles were much less infectious for BHK cells [23] and
were entirely non-infectious for CHO cells (Mertens unpublished),
but retained a high level of infectivity for KC cells. The studies
reported here, treated already purified and intact virus-particles
with proteases, and did not remove the enzymes after treatment.
This could potentially lead to further processing of at least some of
the particles to cores after the initial cleavage events, possibly
explaining the reduced infectivity for BHK cells observed.
In addition, although KC cells have so far shown to be a good in
vitro representation for C. sonorensis (from which larvae these cells
have been generated) [23,40], BHK cells, a standard cell line
commonly used for BTV in vitro studies, are not suited to represent
all of the so far identified numerous mammalian cell targets of
BTV.
Within its mammalian hosts BTV is reported to infect a number
of very different cell types, such as endothelial cells, monocytes,
dendritic cells and lymphocytes [41,42,43] and all of these cells
may exhibit different susceptibilities to the intact virus particles,
ISVP or cores generated during interaction with the insect saliva.
Previous studies have already shown that ISVP have lost their
haemaglutination activity, indicating that their cell binding
properties have changed, particularly for red blood cells.
Additionally leukocytes are known to express a number of integrin
receptors [44] some of which can bind RGD motifs, similar to
those which are present on the upper outer surface of the BTV
VP7 trimers on the core-particle surface [45,46]. It has also
previously been demonstrated that feeding of C. sonorensis on sheep
skin induces a chemo-taxis’ effect, recruiting inflammatory
leukocytes to the biting side, thereby providing potential cellular
targets for BTV infection [47,48]. Future work will therefore
investigate if Culicoides saliva also plays an important role for the
infectivity and virulence of BTV particles for some of the cellular
targets within its natural mammalian host.
In summary, the data presented in this paper demonstrated that
proteases in the saliva of adult Culicoides can directly modify the
structure and the infectivity of BTV and possibly other orbiviruses
they transmit, through cleavage of the outermost viral protein
VP2. This indicates that the transmission efficiency of BTV and
related orbiviruses is likely to be influenced by the composition
and protease activity of the insect vectors’ saliva, as well as ambient
lane 4: +0.5 mg CT, lane 5: mock treated virus particles, lane 6: +0.5 mg T and 30 mg CTInh, lane 7: +1 mg S and 30 mg CTInh, lane 8: +0.5 mg CT and
30 mg CTInh, lane 9: +0.01 mg T and 30 mg CTInh, lane 10: +0.05 mg T and 30 mg CTInh, lane 11: +0.01 mg T; lane 12: +0.05 mg T. (Picture generated
from two gels, not all lanes shown). The a-chymotrypsin inhibitor does not inhibit the cleavage of BTV-1 VP2 by trypsin but has a partial inhibition
effect on the cleavage of VP2 by C. sonorensis saliva proteins. Panel C: lane 1: mock treated virus particles, lane 2: +0.5 mg T; lane 3: +1 mg S ; lane 4:
mock treated virus particles, lane 5:+0.5 mg T and 2 mg TInh, lane 6: +1 mg S and 2 mg TInh, lane 7: +1 mg S and 4 mg TInh, lane 8: mock treated virus
particles, lane 9: +0.05 mg CT, lane 10: +0.05 mg CT and 2 mg TInh (Picture generated from two gels not all lanes shown). Cleavage of BTV-1 VP2 by
trypsin is completely inhibited by the trypsin inhibitor, however the protease activity of C. sonorensis saliva is only partially inhibited.
doi:10.1371/journal.pone.0017545.g007
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temperatures, the protease sensitivity of the virus outer coat
protein, and the host cell susceptibility to protease cleaved particles
(both in the vector and ruminant).
The findings presented in this paper may not only be of
relevance for orbiviruses and their Culicoides vector. The possibility
remains that other arboviruses could also be modified directly by
their arthropod vector saliva, and to elucidate such mechanisms
would be of major importance to fully understand and eventually
prevent arbovirus transmission.
Materials and Methods
Culicoides spp.
Colonies of two different Culicoides species are maintained in the
insectary at the Pirbright Laboratory, of the Institute for Animal
Health. The colony of C. nubeculosus (a European species
considered to be a poor or ‘‘non-vector’’ species for BTV) has
been maintained for more than 30 years. The colony of C.
sonorensis (considered to be the major BTV vector in North
America) was originally established at the USDA laboratory in
Laramie, and an ‘offshoot’ colony has been maintained at IAH
Pirbright for .30 years [49]. The C. sonorensis colony includes two
distinct strains, one of which has been selected to be ‘vector-
competent’ for orbivirus transmission (e.g. BTV and AHSV), while
the other ‘refractory’ colony was selected for low vector
competence for AHSV and BTV [29,32].
Collection and purification of Culicoides saliva proteins
The collection and purification of Culicoides saliva proteins was
carried out as described previously for C. nubeculosus [27]. Briefly
saliva was collected by modifying an artificial midge feeding systems
developed for C. nubeculosus and C. sonorensis [50]. The feeding system
consists of an inner and an outer glass chamber. The inner chamber
was either filled with heparinised horse blood or a sugar solution
and sealed with a ParafilmTM (American National Can, Greenwich,
United States). The outer chamber was connected to a water
circulation system to maintain the blood at 37uC. For collection of
saliva, a DuraporeTM filter membrane (Millipore, Eschborn) was
soaked in sucrose solution (5% w/v - to encourage midge feeding)
and placed on top of the ParafilmTM. Finally another layer of
ParafilmTM was placed above the filter membrane to prevent
contamination with non-salivary proteins from the midges. Pill
boxes, containing 250–300 adult Culicoides (both sexes) of either C.
nubeculosus or C. sonorensis were then attached to the saliva collection
system for 20 to 30 min. Saliva proteins were eluted from the filter
membranes in 1 mM CHAPS (OMNILAB) in 50 ml buffer (either
PBS or 0.2 M Tris) on a shaker, overnight at 4uC. The eluted
proteins were washed and concentrated to a final volume of 500–
1000 ml by ultra-filtration using VIVASPIN falcon tubes (size cut-off
3 kDA, Vivascience, Hanover, Germany).
The method was developed using C. nubeculosus and proteins
recovered were sequenced by mass spectrometry as described [27].
All proteins identified were associated with insect saliva; therefore
the method was regarded as successfully generating saliva proteins
in the absence of contaminating proteins from other sources.
Here C. sonorensis saliva proteins to be used in cell cultures were
passed through 0.2 mm filters and subsequently concentrated via
sterile ultra-filtration using VIVASPIN falcon tubes, then washed
with a three-fold volume of sterile 0.2 M Tris/HCl (pH 8).
As the collected Culicoides saliva was washed and concentrated
and all quantification were based on protein quantities, the end-
product of the saliva collection is termed ‘‘saliva proteins’’
throughout this manuscript.
Protein quantification
Quantification of saliva proteins was performed using the
BCATM Protein Assay (Pierce Prod# 23227) as described by the
kit manufacturer. The optical density was read in a DYNEX
MRX ELISA reader and the protein concentrations calculated in
relation to standardized samples, using the DYNEX REVALA-
TION program.
Mass spectrometry and identification of late trypsin in C.
sonorensis saliva proteins
The saliva proteins of C. sonorensis were analysed by electropho-
resis and mass spectrometry as described for C. nubeculosus saliva
proteins [27]. Briefly, the individual saliva proteins were separated
by 2-D SDS-PAGE and the gel was stained with silver, as
described below. The protein spot, which represented a major
difference between C. sonorensis and C. nubeculosus (later identified as
trypsin) was excised and analysed by mass spectrometry using the
Electrospray Ionization Quadruple Time of Flight (QToF)-
Tandem Mass Spectrometry. Amino acid sequences were used
to search the UniProt and/or NCBI database using MASCOT or
the FASTA program.
SDS-Page analysis and silver staining
Two volumes of protein solution were added to one volume of
36 sample buffer (36 SDS sample buffer, substituted with 10%
DTT at 1.25 M; New England Biolabs) and heated for 5 min at
100uC. SDS-PAGE was carried out using 10%, 12% or 15%
polyacrylamide resolving gels, with a 5% stacking gel as described
[51]. Electrophoresis was carried out either using the Protean II
electrophoresis set (Bio-Rad) using 1.5 mm thick gels or the MINI
PROTEAN II cell system (Bio-Rad) with 1 mm thick gels at
240 V/40 mA or 200 V/400 mA respectively. Proteins were fixed
in the SDS-PAGE using 30%methanol+10% acetic acid in dH2O.
Gels were silver stained using the SilverSnapH kit (Pierce)
according to the manufacturer’s instruction. Pre-stained protein
electrophoresis markers (New England Bio Labs) was used to
estimate the molecular masses of individual saliva proteins.
Virus and virus purification
The viruses used in this study were three strains of BTV: namely
BTV-1 (RSArrrr/01), the reference and the vaccine strains of
Figure 8. Infectivity of purified BTV-1 particles for BHK and KC cells following incubation with C. sonorensis saliva, trypsin or
chymotrypsin. Panel A: BTV-1 purified particles (2.5 mg) were incubated either in the absence of proteases, or with 5, 10 or 15 mg of C. sonorensis
saliva proteins, in a final volume of 100 ml for 3 hours at 37uC. Panel B: BTV-1 purified particles (2.5 mg) were incubated either in the absence of
proteases or with 1 or 5 mg of trypsin (T), in a final volume of 100 ml for 3 hours at 37uC. Panel C: BTV-1 purified particles (2.5 mg) were incubated
either in the absence of proteases or with 0.5, 1 or 5 mg of chymotrypsin (CT), in a final volume of 100 ml for 3 hours at 37uC. The treated BTV-1
particles were added to plain media (GMEM) and Log10 dilutions from 21 to 211 were prepared. These dilutions were titrated in either BHK cells or
KC cells in 96 well plates (50 ml/ well and 8 wells/ dilution) and incubated at 37uC or 30uC respectively. The BHK cells were examined for CPE on day 5
and 7 post inoculation. The KC cells were ‘back titrated’ onto new BHK cell plates 7 d.p.i. and the titre determined by reading CPE on day 5 and 7 post
transfer. Each data point represents at least 3–6 individual experiments (standard deviation = error bar). Cleavage of BTV-1 VP2 by different proteases
increased the infectivity of modified particles for KC cells by 10 to 12 fold, while it reduced the infectivity for BHK cells between 2 and .20 fold.
doi:10.1371/journal.pone.0017545.g008
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BTV-16 (RSArrrr/16 and RSAvvvv/16): and two strains of
EHDV-2 (an ‘eastern’ strain AUS1979/05 and a ‘western’ strain
CAN1962/01), all of which were obtained from the IAH reference
collection (http://www.reoviridae.org/dsRNA_virus_proteins/
ReoID/BTV-isolates.htm). All viruses used were purified as
described before [30]. Briefly 40 roller bottles containing BHK
cells at 90% confluence were infected with the appropriate BTV
or EHDV strain. When 100% CPE was achieved virus particles
were purified using discontinuous sucrose density gradients.
Virus particle - saliva protein incubation
Incubation of purified orbivirus particles with proteases was
carried out in a 50 ml volume for SDS-PAGE analysis, while
100 ml reactions were used for cell titrations to measure particle
infectivity. BTV-1 particles were used at a concentration of 2.5 mg
(12.5 ml) per reaction. Enzymes were added (as indicated) and the
final volume was made up by adding 0.2 M TRIS/HCl, pH 8.
The samples were incubated in an Eppendorf PCR machine, to
guarantee constant temperatures, at temperatures (usually at
37uC) and time periods specified in individual experiments. The
same batches of C. sonorensis saliva, trypsin (Sigma T4549) or
chymotrypsin (Sigma C3142) were used for all assays investigating
enzyme activity. The aliquots of the trypsin and the C. sonorensis
saliva were kept at +4uC for 6 weeks without losing activity, but as
chymotrypsin was unstable at +4uC its aliquots were kept at
280uC.
Protease inhibitor and BTV VP2 cleavage
Purified BTV-1 particles (RSArrrr/01) were incubated with
different amounts of trypsin, chymotrypsin and C. sonorensis saliva
proteins, either with or without the respective protease inhibitors
and the final volume (50 ml) was made up by adding 0.2 M TRIS/
HCl, pH 8. Protease inhibitor used for these studies were a serine-
protease inhibitor from the Bowman-Birk inhibitor family (Sigma,
T9777), a-antichymotrypsin (Sigma A9285) and trypsin-inhibitor
S-II (Sigma, T9128).
Cell cultures
BHK-21 cells (European Collection of Cell Cultures (ECACC))
were grown in GMEM medium, containing 5% adult bovine
serum (ABS), 5% tryptose phosphate broth (TPB) and antibiotics
(100 U penicillin/ 10 mg streptomycin per ml) at 37uC with 5%
C02. KC cells [40], an embryonic cell line established from
Culicoides sonorensis larvae [40] were grown in Schneider’s insect
medium supplemented with 10% FCS, antibiotics (100 U
penicillin/ 10 mg streptomycin/ 2.5 mg Amphotericin B per ml)
at 26–30uC.
Titration on insect and mammalian cell lines
BHK cells (approximately 56105 in 100 ml growth medium)
were added to every well of a 96-flatwell micro-titre plate and
incubated over night at 37uC with 5% CO2, to achieve 80%
confluence. The growth medium was replaced with 150 ml
maintenance medium, prior to use for virus titration. KC cells
in 96 well plates were prepared immediately before the titration
with the addition of a cell-suspension (approximately 16106 KC
cells in 150 ml Schneider’s growth medium) to each well.
Hundred ml of virus particles (either intact or incubates with
saliva/ proteolytic enzymes) were added to 900 ml of GMEM
medium and a ten-fold dilution series up to 10211 was prepared.
Fifty ml of the appropriate dilution was added to each well (as 8
fold duplicates/plate) of 96-well plates containing BHK or KC
cells. Media was added to one row as a negative control. The CPE
developed in BHK cells was read at 5 and 7 days post inoculation
and titres were calculated as described by Kaerber (1931) [52]. As
KC cells do not show CPE, 50 ml of supernatant from each well
was transferred to a newly prepared BHK cell plate at 7 days post
inoculation., creating an exact mirror of the original KC cell plate
as a ‘back titration’. The viral titre shown by the new BHK cell
plate was determined at 5 and 7 days post transfer. The BHK cell
plates (1st round of titration) were also transferred to newly
prepared BHK cells to examine if the virus titre would change,
however, as no changes in viral titre were observed, this practice
was discontinued.
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